Long-lasting Neutralizing Antibodies and T Cell Response after the Third Dose of Mrna Anti-Sars-cov-2 Vaccine in Multiple Sclerosis.
FRONTIERS IN IMMUNOLOGY(2023)
Key words
anti-SARS-CoV-2 vaccination,multiple sclerosis,COVID-19,neutralizing antibodies,T-cell response,disease modifying therapies
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined